North America Small Molecule Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Orthopedics, Immunology, Rare Diseases, and Other Therapeutic Areas); Process/Phase (Target Discovery, Target Validation, Lead Generation and Refinement, and Preclinical Development), and Country
Market Introduction
The small molecules drugs are able to enter cells easily because of its low molecular weight. These molecules are better than monoclonal antibodies and other large molecule drugs due to their size, easy convertibility to oral form and cost affectivity. The discovery of novel small molecule entities that are capable of specific interactions represents a significant challenge in the early stages of drug discovery. In the recent years, the small molecules have witnessed significant attention over biologics, as there is an increasing demand for these drugs.
Get more information on this report :
Market Overview and Dynamics
The North America small molecule drug delivery market is expected to reach US$ 26,458.48 million by 2027 from US$ 12,791.35 million in 2019. The market is expected to grow with a CAGR of 9.8% from 2020 to 2027. Factors such as growing numbers of small molecules drug approvals is likely to propel the growth of the market. However, high cost associated with drug development is the major factor hindering the market growth.
Key Market Segments
Oncology segment from therapeutic area held the larger share of the market in 2019. However, rare diseases is anticipated to register the higher CAGR in the market during the forecast period. Based on process/phase, in 2019, the lead generation and refinement segment held the larger share of the market, however, target discovery segment is anticipated to register the higher CAGR in the market during the forecast period.
Major Sources and Companies Listed
Some of the major primary and secondary sources for North America small molecule drug delivery market included in the report are Ministry of Health and Prevention (MoHAP), National Cancer Institute (NCI), World Health Organization (WHO), National Center for Biotechnology Information (NCBI), and National Heart, Lung, and Blood Institute (NHLBI)
Reasons to buy the report
- To understand the North America small molecule drug delivery market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for North America small molecule drug delivery market
- Efficiently plan M&A and partnership deals in North America small molecule drug delivery market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments of North America small molecule drug delivery market.
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in North America
North America Small Molecule Drug Delivery Market –
By Therapeutic Area
- Oncology
- Central Nervous System
- Cardiovascular
- Respiratory
- Orthopedics
- Immunology
- Rare Diseases
- Other Therapeutic Areas
- Target Discovery
- Target Validation
- Lead Generation and Refinement
- Preclinical Development
- North America
- US
- Canada
- Mexico
Company Profiles
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Small Molecule Drug Discovery Market – By Therapeutic Area
1.3.2 North America Small Molecule Drug Discovery Market – By Process/Phase
1.3.3 North America Small Molecule Drug Delivery Market– By Region
2. Small Molecule Drug Delivery Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Small Molecule Drug Delivery – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America
4.3 Expert Opinion
5. North America Small Molecule Drug Delivery Market – Industry Dynamics
5.1 Key Drivers
5.1.1 Growing Numbers of Small Molecules Drug Approvals
5.1.2 Advantages of Small Molecules in Chronic Disease Treatments
5.2 Market Restraints
5.2.1 High Cost Associated With Drug Development
5.3 Market Opportunities
5.3.1 Increasing Small Molecule-Based Pipeline
5.4 Future Trends
5.4.1 Adoption of Artificial Intelligence in Drug Discovery Is Growing
5.5 Impact analysis
6. Small Molecule Drug Delivery Market – Regional Analysis
6.1 North America Small Molecule Drug Delivery Market Revenue Forecast And Analysis
6.2 Market Positioning of Key Players
7. Small Molecule Drug Discovery Market– By Therapeutic Area
7.1 Overview
7.2 Small Molecule Drug Discovery Market Share, by Therapeutic Area, 2019 and 2027 (%)
7.3 Oncology
7.3.1 Overview
7.3.2 Oncology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
7.4 Central Nervous System
7.4.1 Overview
7.4.2 Central Nervous System: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
7.5 Cardiovascular
7.5.1 Overview
7.5.2 Cardiovascular: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
7.6 Respiratory
7.6.1 Overview
7.6.2 Respiratory: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
7.7 Orthopedics
7.7.1 Overview
7.7.2 Orthopedics: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
7.8 Immunology
7.8.1 Overview
7.8.2 Immunology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
7.9 Rare Diseases
7.9.1 Overview
7.9.2 Rare Diseases: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
7.10 Other Therapeutic Areas
7.10.1 Overview
7.10.2 Other Therapeutic Areas: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
8. Small Molecule Drug Discovery Market – By Process/Phase
8.1 Overview
8.2 Small Molecule Drug Discovery Market, by Process/Phase, 2019 and 2027 (%)
8.3 Target Discovery
8.3.1 Overview
8.3.2 Target Discovery: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Target Validation
8.4.1 Overview
8.4.2 Target Validation: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Lead Generation and Refinement
8.5.1 Overview
8.5.2 Lead Generation and Refinement: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Preclinical Development
8.6.1 Overview
8.6.2 Preclinical Development: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
9. Small Molecule Drug Discovery Market – Geographic Analysis
9.1 North America: Small Molecule Drug Discovery Market
9.1.1 Overview
9.1.2 North America: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
9.1.3 North America Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
9.1.4 North America Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Million)
9.1.5 North America: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)
9.1.5.1 US: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.1.1 US: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.1.2 US Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
9.1.5.1.3 US Skin aesthetic devices market, by Process/ Phase – Revenue and Forecast to 2027 (USD Million)
9.1.5.2 Canada: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.2.1 Canada: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.2.2 Canada Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
9.1.5.2.3 Canada Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Million)
9.1.5.3 Mexico: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.3.1 Mexico: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.3.2 Mexico Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
9.1.5.3.3 Mexico Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Million)
10. Impact Of COVID-19 Pandemic On North America Small Molecule Drug Delivery Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
11. Small Molecule Drug Discovery Market –Company Profiles
11.1 Pfizer Inc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Bristol-Myers Squibb Company
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Johnson & Johnson Services, Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Gilead Sciences, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
Table 2. North America Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Million)
Table 3. US Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
Table 4. US Skin aesthetic devices market, by Process/ Phase – Revenue and Forecast to 2027 (USD Million)
Table 5. Canada Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
Table 6. Canada Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Million)
Table 7. Mexico Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
Table 8. Mexico Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Million)
Table 9. Glossary of Terms, Small Molecule Drug Discovery Market
LIST OF FIGURES
Figure 1. Small Molecule Drug Delivery Market Segmentation
Figure 2. Small Molecule Drug Delivery Segmentation – By Region
Figure 3. North America Small Molecule Drug Delivery Market Overview
Figure 4. The Oncology Segment Held Largest Share and Rare Diseases Segment Expected To Grow With Highest Growth Rate
Figure 5. US Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America PEST Analysis
Figure 7. Small molecule drug discovery Market Impact Analysis of Driver and Restraints
Figure 8. North America Small Molecule Drug Delivery Market – Revenue Forecast And Analysis – 2019- 2027
Figure 9. Market Positioning of Key Players In North America Small Molecule Drug Discovery Market
Figure 10. Small Molecule Drug Discovery Market Share, by Therapeutic Area, 2019 and 2027 (%)
Figure 11. Oncology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 12. Central Nervous System: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 13. Cardiovascular: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 14. Respiratory: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 15. Orthopedics: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 16. Immunology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 17. Rare Diseases: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 18. Other Therapeutic Areas: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 19. Small Molecule Drug Discovery Market, by Process/Phase, 2019 and 2027 (%)
Figure 20. Target Discovery: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Target Validation: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Lead Generation and Refinement: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Preclinical Development: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. North America: Small Molecule Drug Discovery Market, by Key Country – Revenue (2019) (USD Million)
Figure 25. North America Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Million)
Figure 26. North America: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)
Figure 27. US: Small Molecule Drug Discovery market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Canada: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. Mexico: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Impact of COVID-19 Pandemic In North American Country Markets
- Pfizer Inc.
- Bristol-Myers Squibb Company
- Johnson & Johnson Services, Inc.
- Gilead Sciences, Inc
- To understand the North America small molecule drug delivery market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for North America small molecule drug delivery market
- Efficiently plan M&A and partnership deals in North America small molecule drug delivery market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments of North America small molecule drug delivery market.
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in North America